The Genomics Market is becoming an important foundation for personalized healthcare as physicians and researchers increasingly use genetic information to understand disease risk, identify biomarkers, and select appropriate treatments. Market Research Future estimates that the market was valued at USD 30.15 billion in 2025 and is expected to reach USD 84.30 billion by 2035, expanding at a CAGR of 10.80% during 2026–2035.
Personalized medicine is one of the most significant growth opportunities in genomics. Genetic information can help healthcare professionals identify molecular differences between patients and support more individualized treatment strategies. The growing availability of genomic testing is particularly relevant in oncology, rare diseases, hereditary disorders, and pharmacogenomics.
Market Research Future identifies precision and personalized medicine as the fastest-growing application segment, with a projected CAGR of 13.1% through 2035. This growth is supported by increasing adoption of pharmacogenomic testing, biomarker-driven therapies, and genomic profiling.
The pharmaceutical industry is also contributing to demand. Genomic technologies can support target identification, biomarker discovery, clinical-trial recruitment, and companion diagnostic development. Pharmaceutical and biotechnology companies are increasingly incorporating genomic data into drug-development strategies to improve the identification of patient populations most likely to respond to specific therapies.
Advances in sequencing are further strengthening the market. Sequencing accounted for approximately 36.7% of the genomics technology market in 2025. Long-read sequencing is gaining attention because it can identify structural variants and genomic regions that may be difficult to characterize using conventional short-read approaches.
Artificial intelligence is also transforming genomic data analysis. AI-assisted variant interpretation can help researchers and laboratories process large datasets and identify potentially meaningful genetic alterations more efficiently. The combination of genomic information with transcriptomic, proteomic, and metabolomic data is creating opportunities for multi-omic analysis.
North America remains the largest regional market, supported by advanced healthcare infrastructure, research investment, reimbursement mechanisms, and widespread clinical adoption. Asia-Pacific is expected to grow rapidly as countries expand genomic research programs and healthcare infrastructure.
As genomic testing becomes more accessible and affordable, personalized medicine is expected to remain a major growth engine. Continued innovation in sequencing, bioinformatics, AI, and clinical interpretation will help expand the role of genomics across modern healthcare.
